BMTP-11

N/A

Report date: 2024/11/29 15:12:16
NME

Base Information

Drug NameBMTP-11
Drug Alias NameBMTP-11
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin 11 receptor alpha modulators
TargetsInterleukin 11 receptor alpha
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe University Of Texas MD Anderson Cancer Center
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A